Profound Medical Corp - Asset Resilience Ratio

Latest as of June 2016: 67.66%

Profound Medical Corp (PRN) has an Asset Resilience Ratio of 67.66% as of June 2016. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CA$7.73 Million
≈ $5.59 Million USD Cash + Short-term Investments

Total Assets

CA$11.42 Million
≈ $8.26 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2015–2016)

This chart shows how Profound Medical Corp's Asset Resilience Ratio has changed over time. Check Profound Medical Corp (PRN) strategic asset index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Profound Medical Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Profound Medical Corp.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CA$0.00 0%
Short-term Investments CA$7.73 Million 67.66%
Total Liquid Assets CA$7.73 Million 67.66%

Asset Resilience Insights

  • Very High Liquidity: Profound Medical Corp maintains exceptional liquid asset reserves at 67.66% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Profound Medical Corp Industry Peers by Asset Resilience Ratio

Compare Profound Medical Corp's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Novocure Ltd
NASDAQ:NVCR
Medical Devices 43.72%
Sinocare Inc
SHE:300298
Medical Devices 3.53%
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
Medical Devices 10.88%
Bactiguard Holding AB (publ)
ST:BACTI-B
Medical Devices 8.12%
Oncosil Medical Ltd
AU:OSL
Medical Devices 0.00%
Anteris Technologies Global Corp
AU:AVR
Medical Devices 33.27%

Annual Asset Resilience Ratio for Profound Medical Corp (2015–2016)

The table below shows the annual Asset Resilience Ratio data for Profound Medical Corp.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2016-12-31 0.00% CA$0.00
≈ $0.00
CA$17.63 Million
≈ $12.75 Million
--
2015-12-31 47.19% CA$7.21 Million
≈ $5.21 Million
CA$15.27 Million
≈ $11.05 Million
--
pp = percentage points

About Profound Medical Corp

TO:PRN Canada Medical Devices
Market Cap
$272.52 Million
CA$376.73 Million CAD
Market Cap Rank
#15233 Global
#453 in Canada
Share Price
CA$10.38
Change (1 day)
+1.17%
52-Week Range
CA$5.35 - CA$12.11
All Time High
CA$35.63
About

Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedb… Read more